Recent Finacing
Recent Raise
Portola Pharmaceuticals is a South San Francisco biotech developing oral Factor Xa inhibitors, a recombinant Factor Xa antidote, and oral antiplatelet and Syk-inhibitor therapies for thrombotic and inflammatory conditions.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors